Kentucky cancer clinic office manager pleads guilty to selling misbranded chemotherapy drugs

Hematology and Oncology Center (HOC) PLLC and HOC’s former office manager, Natarajan Murugesan, pleaded guilty on June 18, 2014 to purchasing and selling unapproved and improperly labeled chemotherapy drugs. Between January 2010 and July 2011, Murugesan ordered non-FDA approved cancer treatments from Quality Speciality Products (QSP), a subsidiary of Canada Drugs that sold prescription medicines…

[...]

Missouri Clinic Manager Sentenced for Receiving Misbranded Botox

Thomas Greg Martin was sentenced to six months of home confinement, 120 hours of community service, a forfeiture of $32,000 and three years of probation for receiving misbranded Botox® from a foreign, unlicensed drug wholesaler. Thomas operated Aestheticare LLC, a medical clinic with several locations which provided cosmetic procedures to patients in St. Louis County,…

[...]

San Diego Pharmacist Pleads Guilty in Misbranded Cancer Drug Case

Alvarado Medical Pharmacy owner and pharmacist, William Burdine, pleaded guilty December 4th, 2013 to health care fraud in charges pertaining to his purchase and sale of illegally imported cancer medications from a known supplier of counterfeit cancer medication, Quality Specialty Products (QSP). QSP based in Winnepeg, Canada, was previously identified as one of the foreign…

[...]

Florida Man Sent to Prison for 2 Years for Selling Unapproved Imported Cancer Medication

A Florida resident, Martin Paul Bean III has been sentenced to 2 years in prison in a complex counterfeit cancer drug scheme that purchased bulk cancer medications from Pakistan, India, and Turkey. The misbranded oncology drugs were then repackaged and sold as genuine, FDA-approved medications to medical practices throughout the United States. Repackaging work was…

[...]

7 Ohio Oncologists Charged with Illegally Importing Non-FDA approved Cancer Medication

View larger map Seven Ohio oncologists have been charged with illegally importing non-FDA approved cancer medication. The doctors were charged with a misdemeanor violation of the Food, Drug and Cosmetic Act, the purchasing of misbranded or counterfeit drugs. The accused doctors are: Ranjan Bhandari, Timmappa Bidari, David Fishman, Su-Chiao Kuo, Marwan Massouh, Poornanand Palaparty, and…

[...]

Kentucky OBGYN Sentenced to Probation For Purchasing Counterfeit IUDs

View larger map A Kentucky obstetrician/gynecologist, Dr. James Buck, has been sentenced to one year of probation and required to pay over $18,000 in fines after he pled guilty (Download James Buck Plea Agreement) to one misdemeanor count of drug misbranding. Dr. Buck was accused of purchasing unapproved foreign “Mirena” IUDs via a so-called Canadian…

[...]

Clandestine Pharmaceutical Distributor in Virginia That Posed As Canadian Company Shuttered, 11 Indicted

View larger map 11 people have been indicted in an $8.6 million prescription drug importation scheme operating out of Crystal City, Virginia. Called Gallant Pharma International, the business has been shuttered due to allegations that they were operating a prescription drug distribution business illegally and importing non-FDA approved drugs into United States. Once the drugs…

[...]

Tennessee Cancer Doctor Sentenced to 2 Years in Counterfeit Cancer Drug Case

View larger map On June 10, 2013, Dr. William Kincaid of Johnson City, Tennessee was sentenced to two years in prison for his role in purchasing misbranded and possibly counterfeit cancer drugs. Kincaid was a physician and managing partner for McLeod Cancer and Blood Center of Johnson City, Tennessee. The clinic was set up to…

[...]

French Customs Seizes 1.2 Million Doses of Counterfeit Aspirin

View larger map On May 25, 2013, France’s Ministry of Economy announced the largest seizure of counterfeit medication ever made by France and the European Union. French customs agents in Le Havre discovered 1.2 million doses of counterfeit aspirin hidden in a shipment of tea originating from China. The goods in the shipment were destined…

[...]